Catalyst Wire Dossier Catalyst Wire Dossier

IxCell hUC-MSC-S

· Shanghai IxCell Biotechnology Co., LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IxCell hUC-MSC-S, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke [Phase 1]

See pricing